Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Aclara BioSciences  (Stock symbol: ACLA ) Acquired by Monogram Biosciences (2004 $ 200,000,000)

1288 Pear Avenue
Mountain View, CA 94043
Website Company Summary Management Team

Outside board: (May no longer be on the board) Thomas R Baruch (Presidio Partners) John Mendlein (Affinium Pharmaceuticals CEO);  Kevin Tang (Tang Capital Management LLC)

Business description: ACLARA BioSciences, Inc. is developing advanced tools for drug discovery, genomics and proteomics using its proprietary eTagTM assay chemistries and microfluidics expertise. The Company’s products allow researchers to have decision-critical information for drug development, which previously was difficult or impossible to obtain. The solution-phase eTag Assay System is cost-effective, easy-to-use and flexible, and enables highly accurate and precise analysis of genes and/or proteins from limited biological samples. Importantly, researchers can use their existing instrument platforms to perform eTag analyses.
Customers include: Genomics;  diagnostic;  drug discovery
Partners include: Pfizer;  Amersham Biosciences;  Perkin-Elmer

Rounds: 4
Capital raised: 21.3M
Ownership: Acquired by Monogram Biosciences (2004 $ 200,000,000)
Stock Symbol: ACLA
Corporate investors: Perkin-Elmer;  JohnsonAndJohnson

Last Tweets


Last Mentions

Sector: Medical
Year Founded: 1995
Headcount: 151-200 as of Mar 2000
Rounds: 4
Capital Raised: 21.3M
Ownership: Acquired by Monogram Biosciences (2004 $ 200,000,000)
Stock Symbol: ACLA